TRASTUZUMAB EMTANSINE
UNII SE2KH7T06F

Substance Identification & Data

This profile provides standardized clinical and technical data for Trastuzumab Emtansine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) SE2KH7T06F.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1018448-65-1 and the RxNorm Concept ID (RxCUI) 1371041. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

SE2KH7T06F

CAS Registry Number

1018448-65-1

RxNorm Concept ID

1371041

Detailed Substance Profile

Preferred Name

TRASTUZUMAB EMTANSINE

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

SE2KH7T06F

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C82492

National Cancer Institute reference terminology for clinical and research data.

INN ID

9295

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

WW-66

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Trastuzumab Emtansine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.